AstraZeneca PLC (AZN)
166.80
+0.82
(+0.49%)
USD |
NYSE |
Aug 24, 16:00
166.71
-0.09
(-0.05%)
After-Hours: 20:00
AstraZeneca Total Assets (Quarterly) : 114.02B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 114.02B |
| December 31, 2025 | 114.07B |
| September 30, 2025 | 114.46B |
| June 30, 2025 | 112.42B |
| March 31, 2025 | 106.25B |
| December 31, 2024 | 104.04B |
| September 30, 2024 | 104.92B |
| June 30, 2024 | 104.34B |
| March 31, 2024 | 102.29B |
| December 31, 2023 | 101.12B |
| September 30, 2023 | 96.09B |
| June 30, 2023 | 96.54B |
| March 31, 2023 | 96.69B |
| December 31, 2022 | 96.48B |
| September 30, 2022 | 94.18B |
| June 30, 2022 | 96.58B |
| March 31, 2022 | 100.27B |
| December 31, 2021 | 105.36B |
| September 30, 2021 | 107.22B |
| June 30, 2021 | 73.64B |
| March 31, 2021 | 64.93B |
| December 31, 2020 | 66.73B |
| September 30, 2020 | 64.11B |
| June 30, 2020 | 59.93B |
| March 31, 2020 | 57.21B |
| Date | Value |
|---|---|
| December 31, 2019 | 61.38B |
| September 30, 2019 | 58.91B |
| June 30, 2019 | 61.89B |
| March 31, 2019 | 61.06B |
| December 31, 2018 | 60.65B |
| September 30, 2018 | 61.44B |
| June 30, 2018 | 61.34B |
| March 31, 2018 | 63.28B |
| December 31, 2017 | 63.35B |
| September 30, 2017 | 64.59B |
| June 30, 2017 | 65.12B |
| March 31, 2017 | 60.96B |
| December 31, 2016 | 62.53B |
| September 30, 2016 | 63.17B |
| June 30, 2016 | 64.37B |
| March 31, 2016 | 64.20B |
| December 31, 2015 | 60.12B |
| September 30, 2015 | 54.12B |
| June 30, 2015 | 55.17B |
| March 31, 2015 | 53.70B |
| December 31, 2014 | 58.60B |
| September 30, 2014 | 56.16B |
| June 30, 2014 | 58.54B |
| March 31, 2014 | 59.39B |
| December 31, 2013 | 55.90B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| GSK Plc | 81.94B |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
| Merck & Co., Inc. | 129.80B |
| Novo Nordisk A/S | 91.00B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 66.63B |
| Shareholders Equity (Quarterly) | 47.33B |
| Debt to Equity Ratio | 0.7166 |
| Current Ratio | 0.9092 |
| Net Debt Paydown Yield | -0.12% |